Biosino Bio-Technology and Science (HKSE:08247) ROCE % : -13.03% (As of Dec. 2023)

View and export this data going back to 2006. Start your Free Trial

What is Biosino Bio-Technology and Science ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Biosino Bio-Technology and Science's annualized ROCE % for the quarter that ended in Dec. 2023 was -13.03%.

Biosino Bio-Technology and Science ROCE % Historical Data

The historical data trend for Biosino Bio-Technology and Science's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biosino Bio-Technology and Science ROCE % Chart

Biosino Bio-Technology and Science Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

-26.97

5.28

7.43

10.20

-4.44

Biosino Bio-Technology and Science Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROCE %	Get a 7-Day Free Trial															0.58	-5.90	1.40	-0.74	-13.03

Biosino Bio-Technology and Science ROCE % Calculation

Biosino Bio-Technology and Science's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-12.267	/	( ( (673.651 - 386.678)	+	(616.072 - 350.826) )	/ 2 )
	=	-12.267	/	( (286.973	+	265.246)	/ 2 )
	=	-12.267	/	276.1095
	=	-4.44 %

Biosino Bio-Technology and Science's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	-34.552	/	( ( (0 - 0)	+	(616.072 - 350.826) )	/ 1 )
	=	-34.552	/	( ( 0	+	265.246 )	/ 1 )
	=	-34.552	/	265.246
	=	-13.03 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

Biosino Bio-Technology and Science (HKSE:08247) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Biosino Bio-Technology and Science ROCE % Related Terms

Thank you for viewing the detailed overview of Biosino Bio-Technology and Science's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Biosino Bio-Technology and Science (HKSE:08247) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Biosino Bio-Technology and Science Inc (HKSE:08247) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 27 Chaoqian Road, Science and Technology Industrial Park, Changping District, Beijing, CHN, 102200

Website

http://www.zhongsheng.com.cn

Biosino Bio-Technology and Science Inc is engaged in the manufacture, sale, and distribution of in-vitro diagnostic (IVD) reagent products. the company's revenue is generated from customers located in Mainland China.

Executives

Beijing Enterprises Group Company Limited	2201 Interest of corporation controlled by you
Beijing Enterprises Holdings Limited	2101 Beneficial owner
Hk Zhixin Investment Co., Ltd.	2101 Beneficial owner
Li Dongfeng	2201 Interest of corporation controlled by you
Yan Kang	2201 Interest of corporation controlled by you
Qiu Zhe Feng	2201 Interest of corporation controlled by you
Hai Nan Zhi Xin Tou Zi He Huo Qi Ye You Xian He Huo	2201 Interest of corporation controlled by you
Yun Nan Sheng Neng Tou Zi He Huo Qi Ye You Xian He Huo	2101 Beneficial owner
Li Yang Yi Xiong	2201 Interest of corporation controlled by you

Biosino Bio-Technology and Science (HKSE:08247) Headlines

No Headlines